Acupuncture to Reduce Chemotherapy-induced Peripheral Neuropathy Severity During Neoadjuvant or Adjuvant Weekly Paclitaxel Chemotherapy in Breast Cancer Patients

NACompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

February 9, 2015

Primary Completion Date

June 21, 2023

Study Completion Date

June 21, 2023

Conditions
Breast CancerPeripheral Neuropathy
Interventions
PROCEDURE

Acupuncture

Each treatment session will be approximately 40 minutes in duration, 10 minutes to insert needles, 30 minutes to leave needles in. Patients will receive one acupuncture treatment each week until the end of chemotherapy. Adverse effects related to the administration of acupuncture will be collected each week before and after each treatment by the acupuncturist or research study assistant. All Integrative Medicine Service acupuncturists are licensed, credentialed employees of MSK.

BEHAVIORAL

Neuropathic Pain Scale (NPS) questionnaire

It will be collected weekly throughout the screening phase, as well as, at the time of intervention consent, weekly during the intervention, and then once again after the last acupuncture session before the last chemotherapy session.

BEHAVIORAL

FACT/GOG-Ntx questionnaire

It will be collected weekly throughout the screening phase, as well as, at the time of intervention consent, weekly during the intervention, and then once again after the last acupuncture session but before the as the last chemotherapy session, and then once again 3 months (+/-2 weeks) after chemotherapy completion.

Trial Locations (2)

10065

Memorial Sloan Kettering Cancer Center, New York

10604

Memorial Sloan Kettering Westchester, Harrison

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT02364726 - Acupuncture to Reduce Chemotherapy-induced Peripheral Neuropathy Severity During Neoadjuvant or Adjuvant Weekly Paclitaxel Chemotherapy in Breast Cancer Patients | Biotech Hunter | Biotech Hunter